Brand Name: Renocrit 4000 IU Injection Active Ingredient: Recombinant Human Erythropoietin Alfa (Epoetin alfa) – 4000 IU per dose Form: Injection (usually pre‑filled syringe of 0.4 ml) Drug Class: Erythropoiesis‑stimulating agent (ESA) Therapeutic Uses : Renocrit 4000 IU Injection is used to treat or manage anemia caused by: Chronic kidney disease (CKD) – including patients on dialysis or non‑dialysis. Anemia linked to cancer chemotherapy or cancer therapy. Anemia in patients treated with certain antiretroviral drugs (e.g., zidovudine for HIV). It may also be used to reduce the need for red blood cell transfusions before elective surgery in patients at high risk of blood loss. Administration : Route: Injected subcutaneously (under the skin) or intravenously (into a vein) under medical supervision. Dosage: Determined by a doctor based on body weight, hemoglobin levels, and response to treatment. (Active ingredient: Epoetin alfa 4000 IU per 0.4 ml) Main Uses : Anemia due to Chronic Kidney Disease (CKD) Helps increase red blood cell count in patients on dialysis or not on dialysis. Chemotherapy-Induced Anemia Used in cancer patients whose hemoglobin drops due to chemotherapy. HIV-Related Anemia For patients taking antiretroviral therapy (e.g., zidovudine) who develop low hemoglobin. Reduction of Blood Transfusions Pre-surgery or in conditions with expected high blood loss, to reduce the need for red blood cell transfusions. RENOCRIT 4000 IU Injection is a prescription medicine containing Epoetin alfa, used to treat anemia (low red blood cell count) caused by chronic kidney disease (both on and off dialysis), cancer chemotherapy, and HIV treatment (zidovudine). It stimulates bone marrow to produce more RBCs, reducing the need for blood transfusions. Key Uses and Indications : Chronic Kidney Disease (CKD) Anemia: Treats, prevents, or manages anemia in adult and pediatric patients with kidney failure. Cancer Chemotherapy-Induced Anemia: Helps raise hemoglobin levels in patients with non-myeloid malignancies. HIV-Associated Anemia: Manages anemia resulting from zidovudine therapy. Surgery Support: Reduces potential red blood cell transfusions in patients undergoing elective, non-cardiac, non-vascular surgery. How It Works : Renocrit contains a synthetic form of erythropoietin, a hormone that stimulates the bone marrow to produce red blood cells, helping improve oxygen transport and reduce symptoms of anemia. Stimulates the bone marrow to produce more red blood cells. Improves oxygen delivery to tissues and reduces symptoms like fatigue, weakness, and shortness of breath.